tiprankstipranks
Windtree Therapeutics (WINT)
NASDAQ:WINT
US Market

Windtree Therapeutics (WINT) Ownership - Who Owns Windtree Therapeutics?

177 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 28, 2023
Craig Fraser
President & Ceo,director
Bought$2525
Sep 27, 2023
Craig Fraser
President & Ceo,director
Bought$2250
Apr 27, 2023
Craig Fraser
President & Ceo,director
Bought$2650
Apr 26, 2023
Craig Fraser
President & Ceo,director
Bought$2485

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
111,824Insider1.22%37,908
65,075Insider0.71%22,060
49,412Insider0.54%16,751
41,640Institution0.45%14,116
41,640Institution0.45%14,116
31,388Insider0.34%10,641
14,159Institution0.15%4,800

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
41,640Institution0.45%14,116
14,159Institution0.15%4,800

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
41,640Institution0.45%14,741

FAQ

Who Owns Windtree Therapeutics (WINT)?
Currently, no data Available
What percentage of Windtree Therapeutics (WINT) stock is held by institutional investors?
Currently, no data Available
What percentage of Windtree Therapeutics (WINT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Windtree Therapeutics (WINT)?
John G. Cooper owns the most shares of Windtree Therapeutics (WINT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis